Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Hartmann

Showing results (41-50 of 147) with videos related to

Pageof 15
Sort By:
Mayo Clinic Proceedings|August 26, 2003
Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experienceDietlind L Wahner-Roedler, Diana F Nelson, Ivana T Croghan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 6, 2008
Relative weight at age 12 and risk of postmenopausal breast cancerAditya Bardia, Celine M Vachon, Janet E Olson, et al.
International Journal of Cancer|July 29, 2008
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligandsWei He, Sumith A Kularatne, Kimberly R Kalli, et al.
International Journal of Cancer|May 10, 2007
Folate receptor overexpression is associated with poor outcome in breast cancerLynn C Hartmann, Gary L Keeney, Wilma L Lingle, et al.
Archives of Internal Medicine|December 13, 2006
Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor statusAditya Bardia, Lynn C Hartmann, Celine M Vachon, et al.
The American Journal of Surgical Pathology|May 26, 2006
An analysis of breast cancer risk in women with single, multiple, and atypical papillomaJason T Lewis, Lynn C Hartmann, Robert A Vierkant, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesPeter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Annals of Surgical Oncology|September 21, 2010
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancerJudy C Boughey, Tanya L Hoskin, Amy C Degnim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasiaJudy C Boughey, Lynn C Hartmann, Stephanie S Anderson, et al.
Pageof 15

Showing results (41-50 of 147) with videos related to

Sort By:
Pageof 15
Mayo Clinic Proceedings|August 26, 2003
Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experienceDietlind L Wahner-Roedler, Diana F Nelson, Ivana T Croghan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 6, 2008
Relative weight at age 12 and risk of postmenopausal breast cancerAditya Bardia, Celine M Vachon, Janet E Olson, et al.
International Journal of Cancer|July 29, 2008
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligandsWei He, Sumith A Kularatne, Kimberly R Kalli, et al.
International Journal of Cancer|May 10, 2007
Folate receptor overexpression is associated with poor outcome in breast cancerLynn C Hartmann, Gary L Keeney, Wilma L Lingle, et al.
Archives of Internal Medicine|December 13, 2006
Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor statusAditya Bardia, Lynn C Hartmann, Celine M Vachon, et al.
The American Journal of Surgical Pathology|May 26, 2006
An analysis of breast cancer risk in women with single, multiple, and atypical papillomaJason T Lewis, Lynn C Hartmann, Robert A Vierkant, et al.
Plos One|November 19, 2013
The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancerClaudia C Preston, Matthew J Maurer, Ann L Oberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesPeter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Annals of Surgical Oncology|September 21, 2010
Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancerJudy C Boughey, Tanya L Hoskin, Amy C Degnim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasiaJudy C Boughey, Lynn C Hartmann, Stephanie S Anderson, et al.
Pageof 15